These experiments revealed the requirement of RELMβ in both organs for full manifestation of NASH, while deletion of each one alone attenuated the development of NASH with reduced serum lipopolysaccharide (LPS) levels. This evidence concerns the gene RETNLB and metabolic dysfunction-associated steatohepatitis.